Patents by Inventor Joel Barrish

Joel Barrish has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING P38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS
    Publication number: 20090227567
    Abstract: Methods of treating one or more conditions associated with p38 kinase activity are disclosed comprising administering to a patient in need thereof at least one compound having the formula (I): or a pharmaceutically acceptable salt, prodrug, or solvate thereof, wherein R3 is hydrogen, methyl, perfluoromethyl, methoxy, halogen, cyano, or NH2, preferably methyl, and X, R1 through R6, and Z are as described in the specification. Advantageously the groups -ZR4R5 taken together comprise an —NH-substituted aryl.
    Type: Application
    Filed: May 21, 2009
    Publication date: September 10, 2009
    Inventors: Katerina Leftheris, John Hynes, Stephen T. Wrobleski, Joel Barrish
  • Cyclic protein tyrosine kinase inhibitors
    Publication number: 20060079563
    Abstract: Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic and oncologic disorders.
    Type: Application
    Filed: November 10, 2005
    Publication date: April 13, 2006
    Inventors: Jagabandhu Das, Ramesh Padmanabha, Ping Chen, Derek Norris, Arthur Doweyko, Joel Barrish, John Wityak
  • Thiazolyl inhibitors of Tec family tyrosine kinases
    Publication number: 20060030598
    Abstract: Novel thiazolyl compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of Tec family tyrosine kinase-associated disorders such as cancer, immunologic disorders and allergic disorders.
    Type: Application
    Filed: September 27, 2005
    Publication date: February 9, 2006
    Inventors: Joel Barrish, Jagabandhu Das, Steven Kanner, Chunjian Liu, Steven Spergel, John Wityak, Arthur Doweyko, Joseph Furch
  • Cyclic protein tyrosine kinase inhibitors
    Publication number: 20050288303
    Abstract: Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic and oncologic disorders.
    Type: Application
    Filed: May 26, 2005
    Publication date: December 29, 2005
    Inventors: Joel Barrish, John Wityak, Jagabandhu Das, Ping Chen, Derek Norris, Gary Schieven
  • Methods of treating p38 kinase-associated conditions with pyrrolotriazine compounds
    Publication number: 20040229877
    Abstract: Methods of treating one or more conditions associated with p38 kinase activity are disclosed comprising administering to a patient in need thereof at least one compound having the formula (I): 1
    Type: Application
    Filed: October 29, 2003
    Publication date: November 18, 2004
    Inventors: Katerina Leftheris, John Hynes, Stephen T. Wrobleski, Joel Barrish
  • Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
    Patent number: 6670357
    Abstract: Methods of treating one or more conditions associated with p38 kinase activity are disclosed comprising administering to a patient in need thereof at least one compound having the formula (I): or a pharmaceutically acceptable salt, prodrug, or solvate thereof, wherein R3 is hydrogen, methyl, perfluoromethyl, methoxy, halogen, cyano, or NH2, preferably methyl, and X, R1 through R6, and Z are as described in the specification. Advantageously the groups —ZR4R5 taken together comprise an —NH-substituted aryl.
    Type: Grant
    Filed: November 7, 2001
    Date of Patent: December 30, 2003
    Assignee: Bristol-Myers Squibb Company
    Inventors: Katerina Leftheris, John Hynes, Stephen T. Wrobleski, Joel Barrish
  • Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
    Publication number: 20030069244
    Abstract: Methods of treating one or more conditions associated with p38 kinase activity are disclosed comprising administering to a patient in need thereof at least one compound having the formula (I): 1
    Type: Application
    Filed: November 7, 2001
    Publication date: April 10, 2003
    Inventors: Katerina Leftheris, John Hynes, Stephen T. Wrobleski, Joel Barrish